USE OF SMALL MOLECULE INHIBITORS TO KLF10 FOR MODULATION OF T REGULATORY CELLS AND CANCER IMMUNOTHERAPY
申请人:THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
公开号:US20170121318A1
公开(公告)日:2017-05-04
The invention relates to compositions and methods for inhibiting Krüppel-like Factor 10 (KLF10) for modulation of T regulatory cells and cancer immunotherapy.